as 11-07-2025 4:00pm EST
| Founded: | 2020 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 553.7M | IPO Year: | 2025 |
| Target Price: | N/A | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.15 | EPS Growth: | N/A |
| 52 Week Low/High: | $16.70 - $24.03 | Next Earning Date: | 01-01-0001 |
| Revenue: | $3,000,000 | Revenue Growth: | 40.00% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
The information presented on this page, "EVMN Evommune Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.